These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 11720604
1. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group. Gradman AH, Lewin A, Bowling BT, Tonkon M, Deedwania PC, Kezer AE, Hardison JD, Cushing DJ, Michelson EL. Heart Dis; 1999; 1(2):52-7. PubMed ID: 11720604 [Abstract] [Full Text] [Related]
2. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring. Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM. Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350 [Abstract] [Full Text] [Related]
4. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH). Palma Gámiz JL, Pêgo M, Contreras EM, Anglada MP, Martínez JO, Esquerra EA, Sagastagoitia Gorostiza JD, Iberian Multicenter Imidapril Study on Hypertension. Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460 [Abstract] [Full Text] [Related]
5. Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial. Association of Black Cardiologists (ABC) Candesartan Study Group. Heart Dis; 2000 Dec; 2(6):392-9. PubMed ID: 11728289 [Abstract] [Full Text] [Related]
6. The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan. Andersson OK, Neldam S. Blood Press; 1998 Jan; 7(1):53-9. PubMed ID: 9551878 [Abstract] [Full Text] [Related]
7. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study. Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N. Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192 [Abstract] [Full Text] [Related]
11. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators. Lacourcière Y, Asmar R. Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580 [Abstract] [Full Text] [Related]
12. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Palma-Gamiz JL, Pêgo M, Marquez E, Pujol M, Olivan J, Alegría E, Sagastagoitia-Gorostiza JD, Gonzalez-Juanatey JR. Clin Drug Investig; 2007 Dec; 27(6):407-17. PubMed ID: 17506591 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide. Ohma KP, Milon H, Valnes K. Blood Press; 2000 Dec; 9(4):214-20. PubMed ID: 11055474 [Abstract] [Full Text] [Related]
14. Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension. Hoy SM, Keating GM. Am J Cardiovasc Drugs; 2010 Dec; 10(5):335-42. PubMed ID: 20860416 [Abstract] [Full Text] [Related]
15. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. Asmar R, Lacourcière Y. J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784 [Abstract] [Full Text] [Related]
17. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL. Am J Cardiol; 1998 Oct 15; 82(8):961-5. PubMed ID: 9794352 [Abstract] [Full Text] [Related]
18. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM, Zyczynski TM, Leidy NK, Michelson EL, Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol; 2001 Mar 15; 87(6):727-31. PubMed ID: 11249891 [Abstract] [Full Text] [Related]
19. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension. Lee SE, Kim YJ, Lee HY, Yang HM, Park CG, Kim JJ, Kim SK, Rhee MY, Oh BH, Investigators. Clin Ther; 2012 Mar 15; 34(3):552-568, 568.e1-9. PubMed ID: 22381711 [Abstract] [Full Text] [Related]
20. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators. Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL. Am J Cardiol; 1999 Aug 01; 84(3):289-93. PubMed ID: 10496437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]